Atlas Trials

A Safety Trial to Evaluate an Orally Ingested Yeast Modified to Express a Tetra-specific Anti-toxin for Clostridioides Difficile

Clinical trial NCT07649096 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07649096
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Clostridium Difficile Infection
Start date
2026-07-27
Primary completion
2028-08-22
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.